CLINICAL_TRIALS
trial_result
· 2021-12-09
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria [Phase 3]
Summary
Phase 3 trial evaluating Oxabact for primary hyperoxaluria has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OxThera | Conditions: Primary Hyperoxaluria | Phase 3 | Status: COMPLETED | Results posted: 2021-12-09